Showing results (461-470 of 501) with videos related to

Sort By:
Pageof 51
The Journal of Infectious Diseases|March 10, 2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudineS Jankelevich, B U Mueller, C L Mackall, et al.
The Journal of Infectious Diseases|April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trialJ A Kovacs, C Bechtel, R T Davey, et al.
The Journal of Biological Chemistry|December 8, 2004
A neural Wiskott-Aldrich Syndrome protein-mediated pathway for localized activation of actin polymerization that is regulated by cortactinStephan J Kempiak, Hideki Yamaguchi, Corina Sarmiento, et al.
Blood|March 1, 1987
Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphomaG P Schechter, E A Sausville, A B Fischmann, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
The New England Journal of Medicine|January 17, 1991
Dideoxyinosine in children with symptomatic human immunodeficiency virus infectionK M Butler, R N Husson, F M Balis, et al.
Implementation Research and Practice|October 4, 2023
Pragmatic fidelity measurement in youth service settingsLu Wang, Samantha J Stoll, Christopher J Eddy, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markersN K Cheung, B H Kushner, M P LaQuaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of ageB H Kushner, M P LaQuaglia, M A Bonilla, et al.
Pageof 51